CVS Health Raises Full-Year Outlook After Strong Second Quarter

The company posted a GAAP diluted earnings per share (EPS) of $2.31 for the quarter ending June 30, a significant jump from $0.80 in the same period last year. Adjusted EPS reached $2.58, compared to $1.81 in 2025. This performance prompted leadership to raise its full-year 2026 GAAP diluted EPS projection to a range of $6.84 to $7.04, while adjusted EPS guidance moved up to between $7.90 and $8.10.

Chairman and CEO David Joyner attributed the results to a focus on integrated care and technology-powered engagement. The Health Care Benefits segment saw an 85.5% surge in adjusted operating income, largely due to improved underlying performance in government business lines and the absence of prior-year charges. Simultaneously, the company is deploying agentic AI to streamline claims processing through its Aetna Claims Assist Manager, which has reduced processing times for complex claims by more than 20%. Despite these gains, the company maintains a cautious outlook for the remainder of the year, citing elevated cost trends and potential macroeconomic headwinds.